| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a95d0c63b9b3f2bc8e8d6b45fbe7789 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18511 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceb17fd4023cc4a89a7eac3d46230d9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b319d72b609609f7d1bd69d419f8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa46a3cb97e0b6ceb4095ed4e2b30d44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a368a7b5546044c18860d695b7cf71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b40583ec4274aa4e0152768a576c3dc |
| publicationDate |
2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080113223-A |
| titleOfInvention |
Recombinant Polyclonal Antibodies for the Treatment of Respiratory Tract Fusion Virus Infection |
| abstract |
The present invention relates to novel polyclonal antibodies that target respiratory syncytial virus (RSV), and novel high affinity antibody molecules that are reactive with RSV. Polyclonal antibodies can include antibody molecules that are reactive with both RSV protein F and RSV protein G, and preferably, polyclonal antibodies target various epitopes on these proteins. The single antibody molecules of the invention have been shown to have affinity which gives a low dissociation constant in the picomolar range. The invention also relates to methods of providing the antibodies of the invention and methods of their use in the treatment of RSV infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101425405-B1 |
| priorityDate |
2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |